Noninvasix Inc. received a breakthrough device designation from the FDA for its noninvasive Livox central venous oxygenation monitor, which allows real-time monitoring of central venous oxygen ...
重症敗血症患者を対象としたALBIOS試験の後ろ向き解析を実施。試験登録時の中心静脈血酸素飽和度（ScvO2）70％未満の514例と70％以上の961例でScvO2 70％未満の持続と死亡率の関連を評価した。 その結果、登録時のScvO2が70％未満の患者で、6時間後のScvO2 70％未満 ...
ABSTRACT: Introduction: Routinely monitored parameters such as blood pressure (BP) and heart rate may not reliably detect per- fusion abnormalities. However, central venous oxygen saturation (ScvO2) ...
1 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea 2 Department of Emergency Medicine, University of Ulsan, College ...
IRVINE, Calif., Aug. 29 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , the global leader in hemodynamic monitoring technology, announced today the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する